MBX Biosciences (MBX) Prepaid Assets (2023 - 2026)
MBX Biosciences (MBX) reported Prepaid Assets of $8.6 million for Q1 2026, up 1267.25% on a YoY basis from $626000.0 in Q1 2025, and up 9.25% sequentially from $7.8 million in Q4 2025.
MBX Biosciences (MBX) Prepaid Assets (2023 - 2026) Analysis & Trends
MBX Biosciences (MBX) has 4 years of Prepaid Assets data on file, last reported at $8.6 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 1267.25% year-over-year to $8.6 million; the trailing twelve-month figure through Mar 2026 stood at $8.6 million (up 1267.25% YoY), and the FY2025 full-year result was $7.8 million, up 52.5% from the prior year.
- Prepaid Assets rose to $8.6 million in Q1 2026, from $7.8 million in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $8.6 million in Q1 2026 to a low of $133000.0 in Q4 2023.
- A 4-year average of $3.5 million and a median of $2.6 million in 2025 frame the typical range for Prepaid Assets.
- Across the five-year window, Prepaid Assets soared 3762.41% in 2024 and advanced 5.25% in 2025, its largest moves.
- Tracing MBX's Prepaid Assets over 4 years: stood at $133000.0 in 2023, then soared by 3762.41% to $5.1 million in 2024, then surged by 52.5% to $7.8 million in 2025, then rose by 9.25% to $8.6 million in 2026.
- Business Quant data shows MBX's Prepaid Assets at $8.6 million in Q1 2026, $7.8 million in Q4 2025, and $882000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | MBX Biosciences | 2.96 Bn | 2.96 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.56 Mn |
| Dec 31, 2025 | 7.83 Mn |
| Sep 30, 2025 | 882,000.00 |
| Jun 30, 2025 | 4.28 Mn |
| Mar 31, 2025 | 626,000.00 |
| Dec 31, 2024 | 5.14 Mn |
| Sep 30, 2024 | 838,000.00 |
| Dec 31, 2023 | 133,000.00 |